Company: CPSH
Filing Date: 2025-10-06
Form Type: 424B5
Source: 0001437749-25-030558
Chunk: 11

Company: CPS TECHNOLOGIES CORP/DE/
Filing Date: 2025-10-06
Form: 424B5
Chunk 11
---
 us             |              |                              |                                |

(1) The public offering price and underwriting discount corresponds to a public offering price per share of common stock of $ ($ net of the underwriting discount).

(2) We have also agreed to reimburse the representative at closing for legal expenses incurred by it in connection with the offering up to $100,000.

(3) We have granted a 45-day option to the underwriters to purchase up to additional shares of common stock at the public offering price per share of common stock set forth above less the underwriting discount and commission solely to cover over-allotments, if any.

We estimate that our total offering expenses for this offering, net of the underwriting discount and commission, will be approximately $ .

Over-allotment Option

We have granted to the underwriters an option exercisable not later than 45 days after the date of this prospectus supplement to purchase up to an additional shares of common stock at the public offering price per share of common stock set forth above less the underwriting discounts and commissions. The underwriters may exercise the option solely to cover over-allotments, if any, made in connection with this offering. If any additional shares of our common stock are purchased, the underwriters will offer these shares on the same terms as those on which the other shares of common stock are being offered.

Listing

Our common stock is listed on Nasdaq under the symbol “CPSH.” On October 3, 2025, the last reported sale price of shares of our common stock on the Nasdaq Capital Market was $3.41 per share.

<div align='center'>S-8</div>

Lock-Up Agreements

Our directors and officers have entered into lock-up agreements in connection with this offering. Under these agreements, these individuals have agreed, subject to specified exceptions, not to sell or transfer any shares of common stock or securities convertible into, or exchangeable or exercisable for, our common stock during a period ending ninety (90) days following the closing of this offering. Specifically, these individuals have agreed, in part, not to sell, hypothecate, pledge or otherwise dispose of (or enter into any transaction which is designed to, or might reasonably be expected to, result in the disposition (whether by actual disposition or effective economic disposition due to cash settlement or otherwise), or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act, with respect to, any shares of